Jm Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 26-05-2024
- Paid Up Capital ₹ 0.10 M
as on 26-05-2024
- Company Age 20 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
About Jm Lifesciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rashmi Jain and Jayshree Jain serve as directors at the Company.
- CIN/LLPIN
U24232PN2004PTC019030
- Company No.
019030
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Mar 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Jm Lifesciences Private Limited offer?
Jm Lifesciences Private Limited offers a wide range of products and services, including Common Disease Medicines, Injectable Products, Cardiovascular Drugs & Medication, Anticoagulant and Antiplatelet Drugs, Anti Infective Drugs & Medicines, Malaria Medicine, Antibiotic Injection, Brain & Nervous System Drugs, Psychotherapeutic Agents, Antibacterial Drugs.
Who are the key members and board of directors at Jm Lifesciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rashmi Jain  | Director | 08-Jun-2005 | Current |
| Jayshree Jain | Director | 19-Mar-2004 | Current |
Financial Performance of Jm Lifesciences.
Jm Lifesciences Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Jm Lifesciences?
In 2017, Jm Lifesciences had a promoter holding of 95.00% and a public holding of 5.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Jm Lifesciences?
Unlock and access historical data on people associated with Jm Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jm Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jm Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
